United Therapeutics gets June 2027 FDA date for once-daily oral ralinepag
FDA has accepted United Therapeutics’ ralinepag NDA with a June 24, 2027 PDUFA date after ADVANCE OUTCOMES showed a 55% reduction in first clinical worsening events.
Pharma & Biotech